New Merger Announced: Waltz Health and EVERSANA Unite to Reshape Pharmaceutical Services Landscape
Sidley Austin takes the lead in dancing a waltz towards reducing healthcare expenses
In a significant move to revolutionise the pharmaceutical services industry, Waltz Health and EVERSANA have announced their merger. The new CEO of the merged company, Mark Thierer, expressed that the model is built to accelerate access, improve outcomes, and deliver smarter, more transparent drug commercialisation at every step.
The deal, which aims to reshape the pharmaceutical services landscape, is based on a new value-driven model. The goal is to accelerate drug access, improve affordability, and transform drug value throughout the healthcare system. The unified platform will focus on transforming pharmaceutical commercialisation and patient access.
Thierer further stated that the merger will create a platform that connects life sciences innovation directly to the organisations and individuals it serves. The platform will connect life sciences directly to payers and patients, bridging the gap in the pharmaceutical services industry.
The merger aims to combine Waltz Health's digital platform with EVERSANA's pharmaceutical and biotech services. EVERSANA, an independent provider of global services to the life sciences sector, will bring its extensive experience to the table. The former CEO of EVERSANA, Jim Lang, will join as a board member.
The Sidley team, including M&A partner Gary Gerstman, senior managing associate Jeff Wysong, and associate Suzanna Lewis, advised on the merger. The team was based in the firm's Chicago office.
Mark Thierer, co-founder and CEO of Waltz Health, commented on the merger, stating, "This merger is a significant step forward in our mission to deliver lower-cost medications and improve patient access to life-changing therapies."
The merger between Waltz Health and EVERSANA aims to create a unified healthcare platform. The goal is to deliver lower-cost medications and transform the pharmaceutical services industry, making it more accessible and efficient for all involved. The new CEO, Mark Thierer, belongs to the merged company formed by Waltz Health and EVERSANA, and will lead this ambitious endeavour.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant
